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Abstract
Previously, we demonstrated that RBCs inhibit the recurrence of peri-
operatively spilled tumor cells. The aim of this study was to identify on
which RBC component(s) the inhibitory effect is based. By using a cell-
seeding model in rats, the effect of RBC-related antioxidant scavengers
[hemoglobin, catalase, and superoxide dismutase (SOD)] on peritoneal
tumor recurrence was investigated. i.p. injection of hemoglobin caused
45% more tumor load (P < 0.0001). At least 40% inhibition of tumor
recurrence was achieved with the use of catalase or SOD (P < 0.05).
Combining SOD and catalase did not lead to additional inhibition of
tumor recurrence. Inhibition of the overwhelming oxidative potential
after surgical peritoneal trauma with the use of scavengers may lead to
interesting new approaches for diminishing peritoneal tumor recurrence.
Introduction
Local or regional tumor recurrence of gastrointestinal carcinoma
remains an important complication after potentially curative surgical
resection (1). Prevention of this affliction remains the goal of many
clinical and experimental studies (1–3). The results of these studies
show a correlation between surgical peritoneal trauma and locore-
gional tumor recurrence (2, 3). Minimizing surgical trauma, through
the use of laparoscopic surgery or other minimally invasive tech-
niques, was shown to reduce peritoneal trauma and tumor recurrence
(2, 3).
Excessive production of ROS2 and related tissue injury play a
fundamental role in a wide variety of disease processes (4, 5). Besides
by chronic inflammatory diseases, ROS are also produced after sur-
gical trauma (4, 6). The main producers of ROS are inflammatory
cells entering damaged tissue after surgical trauma. The purpose of
these cell products is to destroy invading organisms and damaged
tissue. Despite this beneficial effect, the overwhelming oxidative
potential can result in additional tissue destruction (4, 6).
After peritoneal surgery an acute inflammatory reaction occurs,
even in the absence of any apparent bacterial contamination (7). We
demonstrated recently that the inflammatory sequelae after abdominal
surgery promote tumor recurrence and that this effect is mainly based
on the cellular component of the inflammatory process (3, 8). In the
same experimental model, we showed that RBCs, introduced in the
peritoneal cavity after surgical trauma, effectively inhibited locore-
gional tumor recurrence (9). These studies were performed in a
cell-seeding model and demonstrated that the inhibitory function of
RBCs was primarily based on preventing adhesion of perioperatively
spilled tumor cells. Moreover, we demonstrated that RBC homoge-
nates were equally effective, excluding the possibility of a mere steric
hindrance of tumor cell adhesion.
The aim of this study was to identify which component(s) of the
RBC homogenate could underlie the inhibitory effect of RBCs on
tumor take. For this purpose, the effect of catalase (peroxide decom-
position), hemoglobin (nitric oxide scavenger), and SOD (superoxide
decomposition) were compared with the inhibitory effect of RBCs on
peritoneal tumor recurrence.
Materials and Methods
Animals
Inbred rats of the WAG strain were obtained from Harlan-CPB (Zeist, the
Netherlands). The rats were bred under specific pathogen-free conditions, kept
under standard laboratory conditions (temperature, 20–24°C; relative humid-
ity, 50–60%; 12 h light/12 h dark), fed with laboratory diet (Hope Farms,
Woerden, the Netherlands) and water ad libitum. The experimental protocol
adhered to rules laid down by the Dutch Animal Experimentation Act and was
approved by the Committee for Animal Research of the Erasmus University
Rotterdam.
Tumor Cell Line
CC531 is a moderately differentiated, weakly immunogenic colon adeno-
carcinoma induced in the WAG/Rij rat by 1,2-dimethylhydrazine. A cell line
was established from this carcinoma and maintained by serial passage after
trypsinization in culture medium (10). CC531 tumor cells were cultured in
RPMI 1640 supplemented with 5% FCS, 200 mM L-glutamine, and 105 units/l
penicillin. All supplements were obtained from Life Technologicals BV
(Breda, the Netherlands). Before use, cells were trypsinized (10 min at 37°C),
centrifuged (5 min at 700 3 g), resuspended in RPMI 1640, counted, and
brought to a concentration of 0.5 million cells/ml. Viability was measured by
trypan blue exclusion and always exceeded 90%.
RBC, Catalase, SOD, and Hemoglobin
To obtain RBC concentrate, the same procedure was followed as described
previously (9). In short, WAG/Rij rats were exsanguinated by heart puncture.
The blood was collected in a heparinized vial (heparin Leo; Leo Pharmaceu-
tical Products, Weesp, the Netherlands). RBC concentrate was obtained by
centrifugation of blood at 1000 3 g for 10 min (Mistral 2000 i), removing the
buffy coat and plasma. The pelleted RBCs were resuspended in RPMI 1640 to
the original volume.
Catalase (3000 units/mg, from bovine liver) and hemoglobin (bovine, pre-
pared from washed, lysed, and dialyzed erythrocytes) were purchased from
Sigma-Aldrich Chemie BV (Zwijndrecht, the Netherlands). SOD (5000 units/
mg, from bovine erythrocytes) was purchased from Roche Diagnostics BV
(Almere, the Netherlands). Before use, solutions containing the different
scavengers in the desired concentrations were prepared in PBS and kept on ice.
In Vivo Experiments
Catalase and SOD Determination in RBCs Catalase. Pelleted RBCs
were resuspended in 50 mM phosphate buffer (pH 7.0) to the original volume
Received 3/24/00; accepted 8/24/00.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked advertisement in accordance with
18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom requests for reprints should be addressed, at Laboratory for Experimental
Surgery and Oncology, Erasmus University Rotterdam, P. O. Box 1738, 3000 DR Rot-
terdam, the Netherlands.
2 The abbreviations used are: ROS, reactive oxygen species; SOD, superoxide dis-
mutase; PMN, polymorphonuclear leukocytes.
5625
and diluted 10 times in distilled water to lyse the RBCs at 37°C for 45 min.
Next, the hemolysate was further diluted in phosphate buffer, added in a
volume of 0.02–3 ml of 10.5 mM H2O2, and the time (s) was recorded to obtain
a decrease in absorbance at 240 nm from 0.450 to 0.400. This value was used
to calculate the amount of International Units of catalase/ml sample according
to the formula: 17 3 13.1/(time 3 0.02) (Ref. 11). We found (per ml of
pelleted RBCs) 13563 (6 1252) IU of catalase (n 5 8); thus, 1.5 ml of RBC
concentrate contained 9155 IU.
SOD. The RBC hemolysate was serially diluted in 50 mM phosphate buffer
(pH 7.8) containing 0.1 mM EDTA, 0.01 mM ferricytochrome c, 0.05 mM
xanthine, and 0.025 unit xanthine oxidase/ml. The SOD was assayed on the
basis of its ability to inhibit the reduction of ferricytochrome c at 550 nm by
superoxide anions generated by the xanthine-xanthine oxidase system (12). At
pH 10.0, the SOD appeared about nine times more active and could be
completely inhibited by 1 mM KCN. Pelleted RBCs contained 1096 units of
SOD per ml, which meant that the RBC concentrate contained 750 units of
SOD per 1.5 ml.
Operative Procedure and Tumor Scoring. Under ether anesthesia, the
abdomen of the rats was shaved and cleaned with ethanol 70%. Laparotomy
was performed using a midline incision, followed by i.p. inoculation of 0.5
million CC531 tumor cells. The abdomen was closed in one layer with silk 2-0
sutures (Braun, the Netherlands).
Three weeks postoperatively, the rats were sacrificed, and i.p. tumor load
was scored as described previously (9) at the following sites: parietal perito-
neum (at the site of the incision), omentum, liver, kidneys, retro peritoneum,
and mesentery. The scoring ranged from 0 to 5 per site. A score of 0 meant
there was no tumor growth, a score of 1 indicated an estimated tumor diameter
of ,0.5 cm, a score of 2 a tumor diameter between 0.5 and 1 cm, a score of
3 a tumor diameter between 1 and 2 cm, a score of 4 a tumor diameter between
2 and 3 cm, and a score of 5 an estimated diameter of .3 cm. For each rat, the
scores were summarized and defined as total tumor load.
Effect of Catalase, SOD, and Hemoglobin on Peritoneal Tumor Recur-
rence. In this experiment, the inhibitory effect of RBCs on peritoneal tumor
recurrence was compared with the effect of two major components carried by
RBCs, i.e., catalase and hemoglobin. After laparotomy, 0.5 million CC531
cells were injected into the peritoneal cavity together with 1.5 ml of PBS
(control group, n 5 10), with 1.5 ml RBC concentrate (n 5 10), with 3000
units of catalase (in 1.5 ml of PBS, n 5 10), or 0.5 mg of hemoglobin (in 1.5
ml of PBS, n 5 10).
Next, the effect of a higher concentration of catalase was investigated. After
laparotomy, CC531 cells were injected into the peritoneal cavity together with
1 ml of PBS (control group, n 5 10), with 3000 units of catalase (in 1 ml PBS,
n 5 9), or with 6000 units of catalase (in 1 ml PBS, n 5 9).
Finally, the effect of SOD alone and in combination with catalase was
studied. The experimental groups received 0.5 million tumor cells together
with 6000 units of catalase (n 5 8), with 2000 units of SOD (n 5 8), or with
6000 units of catalase and 2000 units of SOD (n 5 8). To make up for total
volume, 1 ml of PBS was added. The control group (n 5 5) received 2 ml of
PBS and 0.5 million of tumor cells.
Statistical Analysis
Statistical analysis was performed using the nonparametric Kruskal Wallis
ANOVA to determine overall differences, followed by the nonparametric
Mann Whitney U test to compare differences between groups.
Results
Effect of Two Major Components of RBCs versus Intact RBCs
on Peritoneal Tumor Recurrence. After i.p. injection of tumor cells
with RBCs, the inhibition of tumor recurrence was comparable (mean
tumor load 6 SE is 4.9 6 2.0 in RBCs versus 19.3 6 0.9 in control
group, P 5 0.001; Table 1; Fig. 1) with that as found previously (9).
Administration of hemoglobin led to more tumor recurrence
(28.3 6 0.6, P , 0.0001 versus control), with statistically significant
higher tumor diameters at four of six scored peritoneal sites. In the
hemoglobin group, one rat suffered from overload peritoneal tumor
load and was sacrificed before 3 weeks (this rat was excluded for
statistical purposes). Significant differences in peritoneal tumor size
were observed. In the hemoglobin group, 85% of the tumors were .3
cm, compared with 28% in the control and 3% in the RBC group
(Fig. 1B).
When compared with the control, 3000 units of catalase inhibited
tumor recurrence (10.5 6 2.0 catalase, P 5 0.002). Although this was
a statistically significant inhibition, the effect of catalase on peritoneal
tumor load was less than the inhibitory effect of RBCs (P 5 0.008).
In the catalase group, the majority of the tumors (40%) were between
,0.5 and 2 cm in diameter, whereas in the RBC group, 50% was
tumor free. Only 5% of the tumors in the catalase group were ,3 cm
in diameter.
To study whether increasing the amount of catalase would improve
the inhibitory effect on tumor recurrence, 6000 units were adminis-
tered i.p. Total tumor load in the control group of this experiment was
similar to the control in the previous section (mean tumor load 6 SE
is 21.6 6 1.5; Fig. 2A). However, in this experiment, the tumors were
relatively large, i.e., 42% of the tumors were ,3 cm (Fig. 2B),
whereas in the previous experiment, the control tumors were more
heterogeneous in size (Fig. 1B). After i.p. injection of 3000 units of
catalase, mean tumor load amounted to 12.3 6 1.3 (P 5 0.004 versus
control). Tumor load did not decrease significantly using 6000 units of
catalase (12.6 6 2.4, P 5 0.003 versus control).
Using more catalase also did not lead to a further decrease in tumor
size. With 3000 units of catalase, 41% tumors were ,0.5 cm, with
6000 units of catalase 43% (not significant).
Effect of Catalase and SOD on Peritoneal Tumor Recurrence.
To investigate whether SOD could affect tumor recurrence as well,
2000 units of SOD were administered i.p. at the time of tumor
seeding. SOD led to a significant reduction in tumor recurrence in
comparison with the control, respectively, 12.6 6 3.2 and 25 6 2.9
(P , 0.05). The inhibitory effect of 6000 units of catalase was similar,
as described in the previous section (Table 2). The combined admin-
istration of SOD (2000 units) and catalase (6000 units) showed a
minor but not significant stronger inhibition of tumor recurrence
(mean tumor score, 10.6 6 2.3 in the catalase/SOD group; Fig. 3A;
Table 2).
The sizes of tumor deposits in the antioxidant enzyme groups
Table 1 Median tumor load (range) at different peritoneal sites
Median tumor load and range at different abdominal sites in rats having undergone laparotomy followed by i.p. injection of tumor cells with PBS, RBCs, hemoglobin (0.5 g), or
catalase (3000 units). p1 represents differences between rats receiving PBS (control) and RBCs, p2 represents differences between PBS and hemoglobin, p3 represents differences
between PBS and catalase, and p4 represents differences between RBC and catalase.
Abdominal sites
PBS
(n 5 10)
RBCs
(n 5 10)
Hemoglobin
(n 5 9)
Catalase
(n 5 10) p1 p2 p3 p4
Omentum 5 (4–5) 0 (0–5) 5 (5) 1.5 (0–4) ,0.0001 NSa ,0.0001 0.04
Liver 2.5 (2–4) 0 (0–2) 5 (5) 1.5 (0–3) ,0.0001 ,0.0001 0.008 0.03
Kidney 3 (2–5) 1 (0–5) 5 (4–5) 3 (1–5) 0.004 0.002 NS NS
Parietal peritoneum 5 (4–5) 1 (0–3) 5 (5) 1.5 (1–5) ,0.0001 NS 0.001 0.05
Mesentery 2.5 (1–4) 0 (0–4) 3 (2–5) 1.5 (0–4) 0.002 0.05 NS NS
Retro peritoneum 1 (0–3) 0 (0–4) 5 (3–5) 1 (0–2) 0.05 ,0.0001 NS 0.03
Total 19.5 (15–24) 2.5 (1–21) 28 (25–30) 12 (3–21) 0.001 ,0.0001 0.002 0.008
a NS, not significant.
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varied greatly, whereas in the control group, mostly large tumors were
scored (57% ,3 cm). In the control group, 6.7% scored between 0 and
,0.5 cm tumor size, in the SOD group 42%, and in the combined
group 57% (Fig. 3B).
Discussion
The major finding of the present study is that the antioxidant
enzymes SOD and catalase have been identified as the components
that are (partially) responsible for the tumor-inhibiting function of
RBCs. In a previous experimental study, we demonstrated that the
inflammatory sequelae after surgery promote tumor recurrence and
that this effect is mainly based on the cellular component of the
inflammatory process (3, 8). Analysis of the cell population demon-
strated the presence of .75% PMN. In ischemia reperfusion injury,
where related inflammatory mechanisms are at play, most tissue
trauma is inflicted by ROS (13–15). Scavenging of, or blocking, its
production demonstrated that ROS significantly impede wound heal-
ing and graft survival after transplantation (14, 16, 17). Because PMN
are a major source of ROS, similar PMN-related injury might play a
role in surgical peritoneal trauma and tumor recurrence, and likewise,
antioxidants may reduce tumor recurrence.
On the basis of previous results of a tumor-impeding effect of
RBCs, we questioned which RBC component could underlie this
effect. RBCs convey three major scavenging enzymes to diminish the
toxic effects that can be caused by uncontrolled levels of superoxide
radical anions (O2.) or hydrogen peroxide (H2O2). These are SOD,
catalase, and glutathione peroxidase (18). Although hemoglobin is the
principal oxygen carrier, it can scavenge nitric oxide radical as well
(19).
We investigated the effect of hemoglobin and found that tumor
recurrence was in fact increased compared with the control. Catalase
inhibited tumor recurrence .40% in all experiments, showing the
consistency of this effect in vivo. However, the peritoneal tumor load
remaining after catalase injection was significantly higher than after
RBC injection. Although we detected 9000 units of catalase in RBC
concentrate, we did not see a decrease in tumor recurrence when using
a higher amount of catalase in the in vivo experiments. This indicates
an additional tumor impeding effect brought about by RBCs that is not
attained with catalase.
The affinity of catalase for its substrate hydrogen peroxide is low;
in other words, catalase works efficiently only when the concentration
of hydrogen peroxide is high. The finding that catalase is a potent
inhibitor of tumor recurrence indicates that hydrogen peroxide is an
important factor in enhancing peritoneal tumor recurrence. However,
apparently the concentration of this ROS is low, and therefore gluta-
thione peroxidase, another component of RBCs that reduces low
concentrations of hydrogen peroxide in the presence of reduced glu-
tathione with high efficiency (18), may be a better choice.
SOD, another antioxidant enzyme contained by RBCs, dismutates
superoxide to peroxide and oxygen (O2. 1 O2. 1 2H13 H2O2 1 O2).
Experiments investigating ischemia reperfusion injury use SOD to
inactivate the tissue-traumatizing effect of superoxide (13–15). The
results of these experiments show that neutralizing superoxide reduces
tissue injury (15), enhances postoperative wound healing (14), in-
creases bursting pressure of sutured small intestine (14), and increases
graft survival after transplantation (13). In our experiment, 50%
inhibition of tumor recurrence was observed by using this enzyme in
excess (500 units present in RBC concentrate and 2000 units used in
experiments). Apparently, the superoxide anion also promotes tumor
recurrence. However, SOD alone and in combination with catalase
was not more efficient than catalase alone.
The above-mentioned results illustrate that i.p. injection of he-
moglobin stimulates tumor recurrence and that inhibition of hy-
drogen peroxide and superoxide-related tissue trauma diminishes
Fig. 1. A, differences in peritoneal tumor load in rats receiving RBCs and hemoglobin
compared with a control (PBS). The mean of the total tumor score is shown; bars, SE. Ps,
significant differences versus control group. B, distribution of treatment-dependent tumor
size. M, control group; f, RBS; s, hemoglobin.
Fig. 2. A, differences in peritoneal tumor load in rats receiving different concentrations
of catalase. The mean of the total tumor score is shown; bars, SE. Ps, significant
differences versus control group (PBS). B, distribution of treatment-dependent tumor size.
M, control group; f, rats receiving 3000 units of catalase;
 
, rats receiving 6000 units of
catalase.
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tumor recurrence. Taken together, these results provide evidence
for the role of another ROS, i.e., the hydroxyl radical (OHz) as the
real effector molecule in promoting tumor recurrence. Hydroxyl
radicals are extremely reactive, unstable, and powerful free radi-
cals compared with the relatively unreactive peroxide and super-
oxide (4, 5, 15). Catalyzed by iron, peroxide is converted to the
hydroxyl radical in the Fenton reaction (Fe21 1 H2O2 3
Fe31 1 OH2 1 OHz). On its turn, ferric iron is reduced to ferrous
iron by superoxide in the Haber-Weiss reaction (O2. 1 H2O2 3
O2 1 OH2 1 OHz). This may explain why the combination of
SOD and catalase did not lead to a better outcome than each
antioxidant enzyme alone, and why hemoglobin, given as a source
of iron, increased tumor recurrence. It is noteworthy that on a
molar basis, we have administered the same amount of metal (;25
nmol) via hemoglobin (i.e., Fe) and SOD (i.e., Cu) that could
participate in the Fenton reaction. Although direct generation of
free hydroxyl radicals via SOD and hydrogen peroxide is not likely
(20), the introduction of SOD always bears the risk of release of
copper if the enzyme would degrade. The concomitant addition of
compounds that can protect the enzyme from fragmentation may be
considered for this reason (21) and thus may even improve the
inhibitory action of SOD on tumor recurrence. The production of
the hydroxyl radical will ultimately lead to enhanced peritoneal
tissue damage and, hence, enhanced tumor recurrence. Eliminating
superoxide or hydrogen peroxide with SOD and catalase, respec-
tively, prevents the production of the hydroxyl radical. Although
glutathione peroxidase (together with reduced glutathione), based
on its high efficiency to neutralize low hydrogen peroxide concen-
trations, may improve the inhibitory effect on tumor recurrence, a
promising alternative approach may be the use of iron chelators. At
the same time, using such compounds may circumvent the induc-
tion of an immunological reaction, which ultimately will occur
against the exogenous antioxidant enzymes because of a difference
in species between the donor and the recipient. However, it seems
unlikely that such a reaction can explain the results of the present
study because: (a) the development of a full-blown specific im-
mune response needs more time; and (b) despite the source of the
proteins under study was the same, i.e., bovine, their effects on the
inhibition of tumor recurrence were not.
In conclusion, we have shown that inhibition of ROS-mediated
peritoneal damage with the use of scavengers leads to diminished
tumor recurrence. A great deal of insight exists about ROS-mediated
ischemia reperfusion damage and the prevention of this mechanism by
scavengers. Recent studies proclaim improved results against tissue
damage using chemically and biologically stable mimics of SOD and
catalase (22). Inhibition of the overwhelming oxidative potential after
surgical peritoneal trauma (or any other form of surgical trauma) with
the use of scavengers may also lead to interesting new approaches for
diminishing tumor recurrence.
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